Paper39022015
Research progress of Ganoderma lucidum polysaccharide in prevention and treatment of Atherosclerosis.
Ma Y and 7 others. Heliyon, 2024. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Research progress of Ganoderma lucidum polysaccharide in prevention and treatment of Atherosclerosis. Papers, record 39022015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39022015
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Research progress of Ganoderma lucidum polysaccharide in prevention and treatment of Atherosclerosis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References83
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11529255 | Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy. | Curr Pharm Des | 2001 | https://conductscience.org/library/papers/11529255 | PubMed |
| 2 | 27813830 | Macrophage Polarization. | Annu Rev Physiol | 2017 | https://conductscience.org/library/papers/27813830 | PubMed |
| 3 | 22894170 | Chronic stress-induced oxidative damage and hyperlipidemia are accompanied by atherosclerotic development in rats. | Stress | 2013 | https://conductscience.org/library/papers/22894170 | PubMed |
| 4 | 35504280 | Atherosclerosis: Recent developments. | Cell | 2022 | https://conductscience.org/library/papers/35504280 | PubMed |
| 5 | 31769014 | Butyrate protects against high-fat diet-induced atherosclerosis via up-regulating ABCA1 expression in apolipoprotein E-deficiency mice. | Br J Pharmacol | 2020 | https://conductscience.org/library/papers/31769014 | PubMed |
| 6 | 30392496 | The role of polysaccharide peptide of Ganoderma lucidum as a potent antioxidant against atherosclerosis in high risk and stable angina patients. | Indian Heart J | 2018 | https://conductscience.org/library/papers/30392496 | PubMed |
| 7 | 37553709 | Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum. | Lipids Health Dis | 2023 | https://conductscience.org/library/papers/37553709 | PubMed |
| 8 | 29321244 | Silencing carboxylesterase 1 in human THP-1 macrophages perturbs genes regulated by PPARγ/RXR and RAR/RXR: down-regulation of CYP27A1-LXRα signaling. | Biochem J | 2018 | https://conductscience.org/library/papers/29321244 | PubMed |
| 9 | 36506546 | Usnea improves high-fat diet- and vitamin D3-induced atherosclerosis in rats by remodeling intestinal flora homeostasis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36506546 | PubMed |
| 10 | 32052833 | Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. | Eur Heart J | 2020 | https://conductscience.org/library/papers/32052833 | PubMed |
| 11 | 36868439 | Ganoderma lucidum polysaccharides improve lipid metabolism against high-fat diet-induced dyslipidemia. | J Ethnopharmacol | 2023 | https://conductscience.org/library/papers/36868439 | PubMed |
| 12 | 23665276 | Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. | Gastroenterology | 2013 | https://conductscience.org/library/papers/23665276 | PubMed |
| 13 | 26102296 | Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. | Nat Commun | 2015 | https://conductscience.org/library/papers/26102296 | PubMed |
| 14 | 15823385 | Type 2 diabetes: principles of pathogenesis and therapy. | Lancet | 2005 | https://conductscience.org/library/papers/15823385 | PubMed |
| 15 | 28124732 | The improvement of M1 polarization in macrophages by glycopeptide derived from Ganoderma lucidum. | Immunol Res | 2017 | https://conductscience.org/library/papers/28124732 | PubMed |
| 16 | 34131443 | Significant effects of Ganoderma lucidum polysaccharide on lipid metabolism in diabetes may be associated with the activation of the FAM3C-HSF1-CAM signaling pathway. | Exp Ther Med | 2021 | https://conductscience.org/library/papers/34131443 | PubMed |
| 17 | 31387245 | Anti-Proliferative and Pro-Apoptotic Effects of Licochalcone A through ROS-Mediated Cell Cycle Arrest and Apoptosis in Human Bladder Cancer Cells. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31387245 | PubMed |
| 18 | 17183312 | An obesity-associated gut microbiome with increased capacity for energy harvest. | Nature | 2006 | https://conductscience.org/library/papers/17183312 | PubMed |
| 19 | 31672964 | Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. | Nat Commun | 2019 | https://conductscience.org/library/papers/31672964 | PubMed |
| 20 | 33483079 | Suppression of obesity and inflammation by polysaccharide from sporoderm-broken spore of Ganoderma lucidum via gut microbiota regulation. | Carbohydr Polym | 2021 | https://conductscience.org/library/papers/33483079 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959329 | Macrophage lipophagy in atherosclerosis: from molecular mechanisms to traditional Chinese medicine interventions. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42959329 | PubMed |
| 41590417 | Combined Transcriptomic and Metabolomic Analyses of the Response of Ganoderma lucidum to Elevated CO2. | J Fungi (Basel) | 2025 | https://conductscience.org/library/papers/41590417 | PubMed |
| 41475663 | Process-Programmed Extraction-Structure-Activity Relationships (ESAR) in edible and medicinal mushroom polysaccharides: a mechanistic and application-oriented framework. | J Adv Res | 2026 | https://conductscience.org/library/papers/41475663 | PubMed |
| 41128944 | Risk assessment of potentially toxic elements exposure through ganoderma lucidum consumption in the population of Longquan, China. | Environ Geochem Health | 2025 | https://conductscience.org/library/papers/41128944 | PubMed |
| 41113022 | Exploration of the mechanism of Tongmai Jiangzhuo Decoction in treating atherosclerosis based on network pharmacology and experimental validation. | Am J Transl Res | 2025 | https://conductscience.org/library/papers/41113022 | PubMed |
| 40719895 | A review of the extraction technologies, structural characterization, chemical modification, and pharmacological effects of Ganoderma lucidum polysaccharides. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40719895 | PubMed |
| 40427395 | Ganoderma lucidum-From Ancient Remedies to Modern Applications: Chemistry, Benefits, and Safety. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40427395 | PubMed |
| 40099271 | Crosstalk between lipid metabolism and macrophages in atherosclerosis: therapeutic potential of natural products. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40099271 | PubMed |
| 39457856 | The Addition of Hot Water Extract of Juncao-Substrate Ganoderma lucidum Residue to Diets Enhances Growth Performance, Immune Function, and Intestinal Health in Broilers. | Animals (Basel) | 2024 | https://conductscience.org/library/papers/39457856 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39022015
GET https://conductscience.org/api/papers/v1/39022015/references?page=2